Genentech Recalls Prescription Drug Evrysdi Due to Failure to Meet Child Resistant Packaging Requirements; Risk of Drug Exposure through Eye or Skin Absorption (Recall Alert)
CPSC Recall Notice
Source: U.S. Consumer Product Safety Commission (CPSC) — official agency notice for recall CPSC-9021.
This recall involves bottles of the prescription drug Evrysdi, a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older. The recalled 100 mL amber bottles have "Evrysdi (risdiplam) for oral solution," the dosage and "NDC 20242-175-07" on the front of the bottle labels.
Corrective Action (per CPSC)
Source: U.S. Consumer Product Safety Commission (CPSC) — official agency notice for recall CPSC-9021.
Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Select Specialty Pharmacies Nationwide As A Prescribed Medicine From August 2020 Through The Present. The Price Of The Medication Varies Based On Health Insurance Terms And Other Factors. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the CPSC recall page.
- If you've been hurt by this product, report the incident to CPSC.
Consumer Contact (per CPSC)
Source: U.S. Consumer Product Safety Commission (CPSC) — official agency notice for recall CPSC-9021.
Genentech at 800-334-0290 from 8 a.m. to 8 p.m. ET Monday through Friday or online at www.Evrysdi.com and click on the "leaking bottles safety information" banner on the homepage for more information.
About the U.S. Consumer Product Safety Commission
The CPSC protects consumers from injuries and deaths from thousands of types of consumer products — toys, furniture, electronics, appliances, and more.
Visit CPSC.gov →📣 Report an unsafe product to the CPSC
If you own this product and experienced a defect, near-miss, or injury, file a report with the CPSC. Consumer reports are the primary signal the agency uses to identify defect patterns and trigger future recalls. Your report is free, takes about 10 minutes, and can stay anonymous to the manufacturer.
Select Specialty Pharmacies Nationwide As A Prescribed Medicine From August 2020 Through The Present. The Price Of The Medication Varies Based On Health Insurance Terms And Other Factors. Recall FAQ
Select Specialty Pharmacies Nationwide As A Prescribed Medicine From August 2020 Through The Present. The Price Of The Medication Varies Based On Health Insurance Terms And Other Factors. is the subject of a children's products recall: Genentech Recalls Prescription Drug Evrysdi Due to Failure to Meet Child Resistant Packaging Requirements; Risk of Drug Exposure through Eye or Skin Absorption (Recall Alert). The notice was published on March 18, 2021 by the U.S. Consumer Product Safety Commission (CPSC). Approximately 14,000 units are potentially affected.